α-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters

American Journal of Pathology

Volumn 169, Issue 6, 2006, Pages 1913-1924

  Fiaccavento, Roberta ^a,b   Carotenuto, Felicia ^a,b   Minieri, Marilena ^a,b   Masuelli, Laura ^c   Vecchini, Alba ^d   Bei, Roberto ^a   Modesti, Andrea ^a   Binaglia, Luciano ^d   Fusco, Angelo ^a   Bertoli, Aldo ^a   Forte, Giancarlo ^e   Carosella, Luciana ^f   Di Nardo, Paolo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Istituto Nazionale per la Ricerca Cardiovascolare (INRC)   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Syntech Srl   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DELTA SARCOGLYCAN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MYOSIN HEAVY CHAIN; TRANSFORMING GROWTH FACTOR BETA1; EDIBLE OIL; FATTY ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; HAMSTER; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; LIPID COMPOSITION; LONGEVITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; ANIMAL; BLOOD; CARDIOMEGALY; CARDIOMYOPATHY; DIET THERAPY; DISEASE MODEL; HEART CONTRACTION; PATHOLOGY;

ALPHA-LINOLENIC ACID; ANIMALS; CARDIOMEGALY; CARDIOMYOPATHIES; CRICETINAE; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; ENDOMYOCARDIAL FIBROSIS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; LONGEVITY; MYOCARDIAL CONTRACTION;

EID: 35148872478     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051320     Document Type: Article

References (58)

1. Collomb M, Sollberger H, Butikofer U, Sieber R, Stoll W, Schaeren W: Impact of a basal diet of hay and fodder beet supplemented with rapeseed, linseed and sunflowerseed on the fatty acid composition of milk fat. Int Dairy J 2004, 14:549-559
2. Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, van der Schouw YT, Boeing H, Hoffmann K, Boffetta P, Nagel G, Masala G, Krogh V, Panico S, Tumino R, Vineis P, Bamia C, Naska A, Benetou V, Ferrari P, Slimani N, Pera G, Martinez-Garcia C, Navarro C, Rodriguez-Barranco M, Dorronsoro M, Spencer EA, Key TJ, Bingham S, Khaw KT, Kesse E, Clavel-Chapelon F, Boutron-Ruault MC, Berglund G, Wirfalt E, Hallmans G, Johansson I, Tjonneland A, Olsen A, Overvad K, Hundborg HH, Riboli E, Trichopoulos D: Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005, 330:991-998
3. Harper CR, Jacobson TA: Beyond the Mediterranean diet: the role of omega-3 fatty acids in the prevention of coronary heart disease. Prev Cardiol 2003, 6:136-146
4. de Lorgeril M, Salen P: Alpha-linolenic acid and coronary heart disease. Nutr Metab Cardiovasc Dis 2004, 14:162-169
5. Harper CR, Jacobson TA: Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005, 96:1521-1529
6. Klungel OH, Heckbert SR, de Boer A, Leufkens HG, Sullivan SD, Fishman PA, Veenstra DL, Psaty BM: Lipid-lowering drug use and cardiovascular events after myocardial infarction. Ann Pharmacother 2002, 36:751-757
7. Kris-Etherton PM, Hecker KD, Binkoski AE: Polyunsaturated fatty acids and cardiovascular health. Nutr Rev 2004, 62:414-426
8. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB: Dietary α-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005, 112:3232-3238
9. Calder PC: N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004, 107:1-11
10. McLennan PL, Abeywardena MY: Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Membr Biol 2005, 206:85-102
11. Ma DWL, Seo J, Davidson LA, Callaway ES, Fan YY, Lupton JR, Chapkin RS: N-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 2004, 1:1040-1042
12. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K: Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192:1197-1204
13. Pepe S, McLennan PL: Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002, 105:2303-2308
14. Vecchini A, Binaglia L, Di Nardo P, Minieri M, Panagia V, Dhalla NS: Altered lipid metabolism in the failing heart of cardiomyopathic hamsters (UM-X7.1). Prostaglandins Leukot Essent Fatty Acids 1995, 52:199-203
15. Vecchini A, Binaglia L, Bibeau M, Minieri M, Carotenuto F, Di Nardo P: Insulin deficiency and reduced expression of lipogenic enzymes in cardiomyopathic hamster. J Lipid Res 2001, 42:96-105
16. Minieri M, Zingarelli M, Shubeita H, Vecchini A, Binaglia L, Carotenuto F, Fantini C, Fiaccavento R, Masuelli L, Coletti A, Simonelli L, Modesti A, Di Nardo P: Identification of a new missense mutation in the mtDNA of hereditary hypertrophic, but not dilated cardiomyopathic hamsters. Mol Cell Biochem 2003, 252:73-81
17. Masuelli L, Bei R, Sacchetti P, Scappaticci I, Francalanci P, Albonici L, Coletti A, Palumbo C, Minieri M, Fiaccavento R, Carotenuto F, Fantini C, Carosella L, Modesti A, Di Nardo P: Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts. Cardiovasc Res 2003, 60:376-387
18. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA: Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Gene 1997, 6:601-607
19. Di Nardo P, Fiaccavento R, Natali A, Minieri M, Sampaolesi M, Fusco A, Janmot C, Cuda G, Carbone A, Rogliani P, Peruzzi G: Embryonic gene expression in nonoverloaded ventricles of hereditary hypertrophic cardiomyopathic hamsters. Lab Invest 1997, 77:489-502
20. Nakamura T, Matsumoto K, Mizuno S, Sawa Y, Matsuda H, Nakamura T: Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol 2005, 288:H2131-H2139
21. Fiaccavento R, Carotenuto F, Minieri M, Fantini C, Forte G, Carbone A, Carosella L, Bei R, Masuelli L, Palumbo C, Modesti A, Prat M, Di Nardo P: Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy. J Pathol 2005, 205:397-407
22. Hack AA, Lam MJ, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM: Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Science 2000, 113:2535-2544
23. Ambra R, Di Nardo P, Fantini C, Minieri M, Canali R, Natella F, Virgili F: Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters. Life Sci 2002, 71:2369-2381
24. Morise A, Combe N, Boue C, Legrand P, Catheline D, Delplanque B, Fenart E, Weill P, Hermier D: Dose effect of alpha-linolenic acid on PUFA conversion, bioavailability, and storage in the hamster. Lipids 2004, 39:325-334
25. Folch J, Lees M, Sloane-Stanley GM: A simplified method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509
26. Modesti A, Masuelli L, Modica A, D'Orazi G, Scarpa S, Bosco MC, Forni G: Ultrastructural evidence of the mechanisms responsible for interleukin-4- activated rejection of a spontaneous murine adenocarcinoma. Int J Cancer 1993, 53:988-993
27. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S: Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742
28. Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND: Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J Clin Invest 1993, 91:2861-2865
29. Lapidos KA, Kakkar R, McNally EM: The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 2004, 94:1023-1031
30. Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei-Kim, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 2000, 102:246-252
31. Bottinelli R, Schiaffino S, Reggiani C: Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol 1991, 437:655-672
32. Zhang J, Sasaki S, Amano K, Kesteloot H: Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med 1999, 28:520-529
33. Castello L, Froio T, Cavallini G, Biasi F, Sapino A, Leonarduzzi G, Bergamini E, Poli G, Chiarpotto E: Calorie restriction protects against age-related rat aorta sclerosis. FASEB J 2005, 19:1863-1865
34. Owen AJ, Peter-Przyborowska BA, Hoy AJ, McLennan PL: Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 2004, 39:955-961
35. Valentine RC, Valentine DL: Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res 2004, 43:383-402
36. Carrillo-Tripp M, Feller SE: Evidence for a mechanism by which omega-3 polyunsaturated lipids may affect membrane protein function. Biochemistry 2005, 44:10164-10169
37. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M: Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005, 32:563-576
38. Straub V, Duclos F, Venzke DP, Lee JC, Cutshall S, Leveille CJ, Campbell KP: Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan- deficient hamster. Am J Pathol 1998, 153:1623-1630
39. Zhu T, Zhou L, Mori S, Wang Z, McTiernan CF, Qiao C, Chen C, Wang DW, Li J, Xiao X: Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer. Circulation 2005, 112:2650-2659
40. Higginson JR, Winder SJ: Dystroglycan: a multifunctional adaptor protein. Biochem Soc Trans 2005, 33:1254-1255
41. Smith WL: Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 2005, 17:174-182
42. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST: Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003, 100:1751-1756
43. James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S
44. Leaf A, Weber PC: Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988, 318:549-557
45. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197
46. Pepe S: Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol 2005, 40:369-376
47. Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M: Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004, 6:635-641
48. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T: Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 2000, 275:22293-22299
49. Barger PM, Kelly DP: PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 2000, 10:238-245
50. Michalik L, Wahli W: Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 2006, 116:598-606
51. Russell LK, Finck BN, Kelly DP: Mouse models of mitochondrial dysfunction and heart failure. J Mol Cell Cardiol 2005, 38:81-91
52. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP: A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 2003, 100:1226-1231
53. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J: Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005, 293:2884-2891
54. Ander BP, Weber AR, Rampersad PP, Gilchrist JS, Pierce GN, Lukas A: Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic rabbits. J Nutr 2004, 134:3250-3256
55. Paquette F, Jasmin G, Dumont L: Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. Cardiovasc Drugs Ther 1999, 13:525-530
56. Ikeda Y, Gu Y, Iwanaga Y, Hoshijima M, Oh SS, Giordano FJ, Chen J, Nigro V, Peterson KL, Chien KR, Ross J: Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation 2002, 105:502-508
57. Lapidos KA, Chen YE, Earley JU, Heydemann A, Huber JM, Chien M, Ma A, McNally EM: Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J Clin Invest 2004, 114:1577-1585
58. Mozaffarian D: Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence. Curr Atheroscler Rep 2005, 7:435-445